The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, February 15, 2022
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, ...
read more
Thursday, February 17, 2022
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for...
read more
Friday, February 18, 2022
Northwest Biotherapeutics announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its ...
read more
Tuesday, February 22, 2022
Eli Lilly and Company announced the launch of the Lilly Institute for Genetic Medicine and an investment of approximately $700 million to establish a ...
read more
Tuesday, February 22, 2022
BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have ...
read more
Thursday, February 24, 2022
Alvotech Holdings S.A. and Fuji Pharma have agreed to add to their strategic partnership for the development and commercialization of biosimilar ...
read more
Friday, February 25, 2022
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) announced that Health Canada has granted approval for ...
read more
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier,...
read more
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon Biologics...
read more
Wednesday, March 02, 2022
Amneal Pharmaceuticals, Inc. announced the FDA has approved the Biologics License Application (BLA) for filgrastim-ayow, a biosimilar referencing ...
read more
AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-...
read more
Terran Biosciences has entered into an agreement with Concert Pharmaceuticals to acquire a portfolio of Concert's CNS therapeutics and accompanying ...
read more
Elektrofi & IPA announced they are entering into a collaboration to explore a high-concentration formulation of IPA’s COVID-19 antibody cocktail, ...
read more
A German independent research institute, BioMed X, announced the start of its new research project ‘Regulatory T Cell Dysfunction in Autoimmunity and ...
read more
Seagen Inc. and Sanofi announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to ...
read more